All Stories

  1. Design of a Neonatal Orthotopic Metastatic Xenograft Model of Hepatoblastoma in Mice
  2. Enhancing cell instance segmentation in scanning electron microscopy images via a deep contour closing operator
  3. Improving Cell Instance Segmentation in Scanning Electron Microscopy via Semantic Image Synthesis
  4. Optimized zymogram protocol from 3D spheroid cultures to study MMP-2 and -9 activities in tumor cells
  5. DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis
  6. Functions and Therapeutic Use of Heat Shock Proteins in Hepatocellular Carcinoma
  7. Unfolded Protein Response Signaling in Liver Disorders: A 2023 Updated Review
  8. Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1
  9. Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis
  10. Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer
  11. miR-155 regulates physiological angiogenesis but an miR-155-rich microenvironment disrupts the process by promoting unproductive endothelial sprouting
  12. An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect
  13. LIM Homeobox-2 Suppresses Hallmarks of Adult and Pediatric Liver Cancers by Inactivating MAPK/ERK and Wnt/Beta-Catenin Pathways
  14. Deciphering tumour tissue organization by 3D electron microscopy and machine learning
  15. DUSP9, a Dual-Specificity Phosphatase with a Key Role in Cell Biology and Human Diseases
  16. Deciphering Tumour Tissue Organization by 3D Electron Microscopy and machine learning
  17. The ß-catenin-target Fascin-1, altering hepatocyte differentiation, is a new marker of immature cells in hepatoblastomas
  18. 3e colloque de recherche fondamentale en oncologie pédiatrique
  19. The Nuclear Remodeling Induced by Helicobacter Cytolethal Distending Toxin Involves MAFB Oncoprotein
  20. HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53
  21. miR‐4510 Blocks Hepatocellular Carcinoma Development Through RAF1 Targeting and RAS/RAF/MEK/ERK Signaling Inactivation
  22. Les microARNs, de petits régulateurs géniques à fort potentiel thérapeutique en cancérologie
  23. Cytolethal distending toxin induces the formation of transient messenger-rich ribonucleoprotein nuclear invaginations in surviving cells
  24. Expression of miRNA-210 in human bone marrow-derived mesenchymal stromal cells under oxygen deprivation
  25. Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression in vivo
  26. Role of Glycanation and Convertase Maturation of Soluble Glypican-3 in Inhibiting Proliferation of Hepatocellular Carcinoma Cells
  27. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma
  28. SimBA: A methodology and tools for evaluating the performance of RNA-Seq bioinformatic pipelines
  29. New tumor suppressor microRNAs target glypican-3 in human liver cancer
  30. MicroRNA therapy inhibits hepatoblastoma growthin vivoby targeting β-catenin and Wnt signaling
  31. MicroRNA-1291-mediated silencing of IRE1  enhances Glypican-3 expression
  32. A functional screening identifies five micrornas controlling glypican-3: role of mir-1271 down-regulation in hepatocellular carcinoma
  33. Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model
  34. Analysis of post-transcriptional regulation using the FunREG method
  35. A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia
  36. A mutation in the 3′-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia
  37. Analysis of Post-transcriptional Regulations by a Functional, Integrated, and Quantitative Method
  38. Ultrasound-Induced Expression of a Heat Shock Promoter-Driven Transgene Delivered in the Kidney by Genetically Modified Mesenchymal Stem Cells
  39. The ARE-associated factor AUF1 binds poly(A) in vitro in competition with PABP
  40. Le CD154 plaquettaire : Une nouvelle interface dans l’hémostase et la réaction inflammatoire
  41. Platelet-associated CD154 in immune thrombocytopenic purpura
  42. In Vivo MR Imaging of Intravascularly Injected Magnetically Labeled Mesenchymal Stem Cells in Rat Kidney and Liver1
  43. In VivoStudies of Translational Repression Mediated by the Granulocyte-Macrophage Colony-stimulating Factor AU-rich Element
  44. Prostaglandin E2modulates dendritic cell function via EP2and EP4receptor subtypes
  45. Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism
  46. Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis
  47. Dendritic Cells Issued in Vitro from Bone Marrow Produce PGE2 That Contributes to the Immunomodulation Induced by Antigen-Presenting Cells
  48. A Mechanism for Translationally Coupled mRNA Turnover
  49. Differential effect of interferon alpha on chronic myelogenous leukaemia and normal haematopoietic progenitors in a stromal cell co-culture context: role of the flt3 ligand
  50. Expression of Flt3-ligand by the endothelial cell
  51. LEUKAEMIA INHIBITORY FACTOR EXPRESSION IS INHIBITED BY GLUCOCORTICOIDS THROUGH POST-TRANSCRIPTIONAL MECHANISMS
  52. Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids
  53. CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells.
  54. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside